Prescribing pattern of higher generation antibiotics in the out-patient setting in Bhutan hospitals

1. World Health Organization: WHO infectious disease report: leading cause of death. Vol. 2004, 1999.Search in Google Scholar

2. Rubin MA, Samore MH. Antimicrobial use and resistance. Curr Infect Dis Rep. 2002; 4:491-7.10.1007/s11908-002-0034-yOpen DOISearch in Google Scholar

3. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003; 36:1433-7.10.1086/375081Search in Google Scholar

4. World Health Organization: WHO global strategy for containment of antimicrobial resistance. WHO/CDS/ DRS/2001.2: WHO, Geneva, 2001.Search in Google Scholar

5. Byarugaba DK. Antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004; 24:105-10.10.1016/j.ijantimicag.2004.02.015Search in Google Scholar

6. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother. 2002; 46:2540-5.10.1128/AAC.46.8.2540-2545.2002Search in Google Scholar

7. Niyogi SK, Dutta P, Mitra U. Trends in antimicrobial resistance of Shigella species isolated from children with acute diarrhea. Indian Pediatr. 2000; 37:339-41.Search in Google Scholar

8. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999; 5:18-27.10.3201/eid0501.990103Search in Google Scholar

9. Patel SJ, Larson EL, Kubin CJ, Saiman L. A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations. Pediatr Infect Disease J. 2007; 26: 531-7.10.1097/INF.0b013e3180593170Search in Google Scholar

10. Capoor MR, Nair D, Deb M, Aggarwal P. Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins. J Med Microbiol. 2007; 56:1131-2.10.1099/jmm.0.47170-0Search in Google Scholar

11. Patrick DM, Marra F, Hutchinson J, Monnet DL, Ng H, Bowie WR. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? Clin Infect Dis. 2004; 39:11-7.Search in Google Scholar

12. Buetow SA, Sibbald B, Cantrill JA, Halliwell S. Appropriateness in health care: application to prescribing. Social Sci Med. 1997; 45:261-71.10.1016/S0277-9536(96)00342-5Open DOISearch in Google Scholar

13. Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992; 45: 1045-51.10.1016/0895-4356(92)90144-COpen DOISearch in Google Scholar

14. Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994; 47: 891-6.10.1016/0895-4356(94)90192-9Open DOISearch in Google Scholar

15. Sandiumenge A, Diaz E, Rodriguez A, Vidaur L, Canadell L, Olona M, et al. Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother. 2006; 57:1197-204.10.1093/jac/dkl097Search in Google Scholar

16. Zervos MJ, Hershberger E, Nicolau DP, Ritchie DJ, Blackner LK, Coyle EA, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis. 2003; 37:1643-8.10.1086/379709Search in Google Scholar

17. Tunger O, Dinc G, Ozbakkaloglu B, Atman UC, Algun U. Evaluation of rational antibiotic use. Int J Antimicrob Agent. 2000; 15:131-5.10.1016/S0924-8579(00)00158-8Search in Google Scholar

18. LeMire M, Wing L, Gordon DL. An audit of third generation cephalosporin prescribing in a tertiary care hospital. Aust N Z J Med. 1996; 26: 386-90.10.1111/j.1445-5994.1996.tb01927.x8811213Search in Google Scholar

19. Pickering TD, Gurwitz JH, Zaleznik D, Noonan JP, Avorn J. The appropriateness of oral fluoroquinoloneprescribing in the long-term care setting. J Am Geriatr Soc. 1994; 42: 28-32.10.1111/j.1532-5415.1994.tb06069.x8277111Open DOISearch in Google Scholar

20. Pinto Pereira L, Phillips M, Ramlal H, Teemul K, Prabhakar P. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy. BMC Infect Dis. 2004; 4:59.10.1186/1471-2334-4-5954506415601475Open DOISearch in Google Scholar